surmount-1 tirzepatide weight loss non-diabetic trial nondiabetic SURMOUNT 1 // Three-Year Obesty & Diabetes Prevention Outcomes Gastrointestinal tolerability and weight reduction

1,2 Lean Mass Preservation and Fat Reduction Outcomes Results, which included data from approximately 50% of participants after 26 weeks, show that semaglutide alone led to an average weight loss of 23 pounds, with 34.5% of that weight loss attributed to reductions in lean muscle mass

Individual timing and severity can vary

Chelsea Handler When hosting the 2023 Critics' Choice Awards, comedian Chelsea Handler joked that A-listers everywhere were claiming they slimmed down by chugging water, but that "really it's because everyone's on Ozempic" (via Access Hollywood)

Now is the time to move towards the goals of a healthier lifestyle